Johns Hopkins

We are funding a clinical trial at Johns Hopkins to test whether mebendazole, a drug already approved by the FDA to fight infections, might be an effective anti-brain cancer medication.  This drug has a sgtrong safety profile and is available as a generic, which could be widely available in the near term and at a low cost to patients.